Evidence map›Paper›PMID 39084811›Full record

ReviewEndocrinology and metabolism clinics of North America2024

Diagnosis and Treatment of Hyperglycemia in Pregnancy: Type 2 Diabetes Mellitus and Gestational Diabetes.

Sneha Mohan, Aoife M Egan

Abstract readReview
In one paragraph

Review in Endocrinology and metabolism clinics of North America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Metformin Inhibits Trophoblast Ferroptosis by Suppressing ATF2 and Activating the PI3K/Akt/Nrf2 Pathway to Improve Gestational Diabetes Mellitus.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Article
  3. Article
  4. Therapeutic effects of 1,25-dihydroxyvitamin DMolecular biology reports · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sneha MohanDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA. Electronic address: https://twitter.com/SnehaMohanEndo.
Aoife M EganDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA. Electronic address: Egan.Aoife@mayo.edu.

Funding

Elucidating the Pathophysiology of Gestational Diabetes MellitusK23DK134767 · NIDDK · MAYO CLINIC ROCHESTER · PI Aoife Maria Egan · 2023 to 2026
$762k
NIDDK NIH HHS K23 DK134767
6 · The paper itself

Abstract

Hyperglycemia in pregnancy due to pre-existing Type 2 diabetes mellitus (T2DM) and gestational diabetes mellitus (GDM) is rising globally with increasing rates of risk factors for metabolic disease. This review summarizes current evidence and recommendations from national and international guidelines for diagnosis and management of T2DM and GDM to optimize maternal and neonatal outcomes.

Indexed as

Diabetes, GestationalDiabetes Mellitus, Type 2HyperglycemiaFemaleHumansHypoglycemic AgentsPregnancyPregnancy in DiabeticsHypoglycemic AgentsGestational diabetes mellitus (GDM)InsulinMetforminPregnancyType 2 diabetes (T2DM)

Identifiers

PMID39084811
PMCPMC11296496

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.